Definition and symptoms
AOM is an infection of the middle ear space that can be viral, bacterial or coinfection. The most common bacterial organisms causing otitis media are Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.7
Regardless of the causative organism, most AOM is self-limiting.2
AOM can occur at any age, but is most common in children aged 6–24 months.
Risk assessment
When treating a child with symptoms of AOM, first:
- exclude serious conditions that could either be the cause or be masked by AOM, such as acute mastoiditis and meningitis
- identify if they are at high risk.
Refer to ‘Red flags’ for further details.
Antibiotic therapy
Pharmaceutical Benefits Scheme (PBS) data shows that the highest rate of antibiotic dispensing for patients aged <65 years is for children aged 2–4 years.8,9 AOM is one of the most common diseases in childhood for which antibiotics are prescribed.1
For children with AOM who are not at high risk, antibiotic therapy has a limited benefit 1,2,7 because:
- initial antibiotic therapy does not improve pain at 24 hours
- most children will be better after about four days without taking antibiotics, and for every 100 children treated with antibiotics, only five additional children will be better at 2 to 3 days as a result of taking antibiotics
- antibiotics shorten the duration of symptoms by an average of about only 12 hours.
A 2023 Cochrane systematic review found that:
1
- compared to a placebo, antibiotics did slightly reduce the number of children who developed perforations of the eardrum and the number of children who developed AOM in the ear that was initially unaffected
- antibiotics reduced the number of children with abnormal tympanometry findings at two to four weeks, but not after six to eight weeks, nor at three months
- there was not enough information to determine if antibiotics reduced the occurrence of rare complications such as mastoiditis (infection of the bones around the ear)
- antibiotics caused unwanted effects such as diarrhoea, vomiting and rash.
The review concluded that it is difficult to balance the small benefits against the small harms of antibiotics in children with AOM, and that for most children with mild disease in high‐income countries, a watchful waiting approach seems justified.